Glenmark Pharmaceuticals informs about press release

13 Jul 2022 Evaluate
Glenmark Pharmaceuticals has informed that it enclosed a copy of press release regarding - Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize''s Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal.

The above information is a part of company’s filings submitted to BSE.


Glenmark Pharma Share Price

2001.05 30.30 (1.54%)
27-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.30
Dr. Reddys Lab 1240.00
Cipla 1312.85
Zydus Lifesciences 893.45
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×